The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000645358p
Ethics application status
Help: Ethics application status
Submitted, not yet approved
Date submitted
Help: Date submitted
7/05/2026
Date registered
Help: Date registered
28/05/2026
Date last updated
Help: Date last updated
28/05/2026
Date data sharing statement initially provided
Help: Data sharing statement date
28/05/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
REFRESH-Ovarian: Feasibility of a Stepped-Care Cognitive Behavioural Therapy Program for Australians with Ovarian Cancer and Cancer Fatigue
Scientific title
REFRESH-Ovarian: A hybrid type 2 pilot examining the acceptability, appropriateness, and feasibility of a stratified, telehealth, stepped-care cognitive behavioural therapy program for cancer-related fatigue in Australians with ovarian cancer.
Additional trial identifiers [1] 317215 0
Nil known
Universal Trial Number (UTN)
Trial acronym
Refresh-Ovarian
Related trial records
ACTRN12622000420741
The current trial is informed by a previous small pilot study examining the acceptability and feasibility of telehealth stepped-care cognitive behavioural therapy for cancer-related fatigue Australians with cancer across tumour streams. The intervention is being adapted to specifically address the needs of Australians with ovarian cancer and catering to rural and remote living.

Health condition
Health condition(s) studied:
Ovarian Cancer 341821 0
Cancer-related fatigue 341822 0
Condition category
Condition code
Cancer 337894 337894 0 0
Ovarian and primary peritoneal

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
The Refresh-Ovarian program is cost-free, telehealth, stratified, stepped-care cognitive behavioural therapy (CBT) for cancer-related fatigue (CRF) tailored to people with ovarian cancer. The program aims to screen and offer referral to CBT treatment.

Participants enrolled in the program will receive:
(i) the REFRESH-Ovarian CBT workbook. This workbook has been specifically designed for this study and consists of five chapters designed to be completed over five weeks, It includes short readings and 20 tasks based on CBT for fatigue (e.g. activity diary, pacing, relaxation practice, thinking traps). Chapter summary: (1) About cancer-related fatigue (overview of CRF, factors contributing to CRF, and ways to manage CRF) , (2) Behaviours to help fatigue (how behaviours impact fatigue, behavioural activation, physical activity and exercise, energy management, pacing, effective rest); (3) Fatigue and your feelings (how feelings, including stress and anxiety contribute to fatigue, relaxation and mindfulness skills), (4) Your thoughts about fatigue (thought-feeling connection, identifying/reframing unhelpful thoughts, self-compassion, managing worries, coping statements) , (5) Moving on (coping card summarising skills, information on how sleep, mood, pain and diet can impact fatigue, further supports and resources).
(ii) psychologist support (e.g., phone-coaching or group CBT) based on a person's baseline level of CRF (i.e. mild-to-severe). There is an option to for participants who are initially recommended Step 2 to start with Step 1 if they prefer.

STEP 1 – Self-Management (for mild-to moderate fatigue):
2x Coaching Calls (approx. 30mins duration, at Week 2-3, and Week 5-6) with a clinical psychologist over five weeks to provide tailored support (e.g., psychoeducation, problem-solving, goal-setting), monitor adherence (e.g., completion of relevant chapter reading and tasks), and address any concerns raised while independently completing the CBT workbook. Participants' will be rescreened for CRF at the completion of 5 weeks.

STEP 2 – Group CBT (for severe fatigue)
5x Group CBT sessions with a clinical psychologist (approximately 60 minutes long, online via telehealth) over six weeks. Sessions will run weekly, with a one-week break between session 3 and session 4 to support consolidation of CBT skills. Groups will be small (around 2-6 people) to ensure each person can receive tailored support (e.g., psychoeducation, problem-solving, goal-setting). Topics covered in CBT sessions will align with booklet chapters.

All participants will be rescreened for CRF after completing their initial intervention step. Those whose CRF levels remain unchanged or worsened from screening will have a treatment planning discussion of further needs and treatment options (e.g. referral to STEP 2, community support services and/or their GP for follow-up).
Intervention code [1] 333987 0
Behaviour
Intervention code [2] 333989 0
Treatment: Other
Description of the comparator or control
No control group
Control group
Uncontrolled

Outcomes
Primary outcome [1] 345340 0
Acceptability of the stepped-care CBT program for fatigue among (i) people with ovarian cancer (service user) (ii) clinicians (service adopter)
Timepoint [1] 345340 0
(i) Within two weeks post-intervention - i.e. approximately Week 6-7 after completing Step 1 (T2a) or Step 2 (T2b) only, OR Week 14 after completing Step 1 AND Step 2 (ii) pre-implementation (T0), ongoing during data collection
Primary outcome [2] 345341 0
Appropriateness of the stepped-care CBT program for fatigue among (i) people with ovarian cancer (service user) (ii) clinicians (service adopter)
Timepoint [2] 345341 0
(i) Within two weeks post-intervention - i.e. approximately Week 6-7 after completing Step 1 (T2a) or Step 2 (T2b) only, OR Week 14 after completing Step 1 AND Step 2 (ii) pre-implementation (T0), ongoing during data collection
Primary outcome [3] 345342 0
Feasibility of the stepped-care CBT program for fatigue among (i) people with ovarian cancer (service user) (ii) clinicians (service adopter)
Timepoint [3] 345342 0
(i) Within two weeks post-intervention - i.e. approximately Week 6-7 after completing Step 1 (T2a) or Step 2 (T2b) only, OR Week 14 after completing Step 1 AND Step 2 (ii) pre-implementation (T0), ongoing during data collection
Secondary outcome [1] 461331 0
Cancer-related fatigue
Timepoint [1] 461331 0
(i) At Baseline (T1) - Week 0 (ii) Within two weeks post-intervention - i.e. approximately Week 6-7 after completing Step 1 (T2a) or Step 2 (T2b) only, OR Week 14 after completing Step 1 AND Step 2 (iii) 2mo post-intervention follow-up (T3) - ie., approximately Week 14 after completing Step 1 (T2a) OR Step 2 (T2b) only, or Week 21 after completing Step 1 AND Step 2
Secondary outcome [2] 461332 0
Self-efficacy or confidence to manage fatigue
Timepoint [2] 461332 0
(i) At Baseline (T1) - Week 0 (ii) Within two weeks post-intervention - i.e. approximately Week 6-7 after completing Step 1 (T2a) or Step 2 (T2b) only, OR Week 14 after completing Step 1 AND Step 2 (iii) 2mo post-intervention follow-up (T3) - ie., approximately Week 14 after completing Step 1 (T2a) OR Step 2 (T2b) only, or Week 21 after completing Step 1 AND Step 2
Secondary outcome [3] 461333 0
Participation and activity levels
Timepoint [3] 461333 0
(i) At Baseline (T1) - Week 0 (ii) Within two weeks post-intervention - i.e. approximately Week 6-7 after completing Step 1 (T2a) or Step 2 (T2b) only, OR Week 14 after completing Step 1 AND Step 2 (iii) 2mo post-intervention follow-up (T3) - ie., approximately Week 14 after completing Step 1 (T2a) OR Step 2 (T2b) only, or Week 21 after completing Step 1 AND Step 2
Secondary outcome [4] 461334 0
Sedentary behaviour
Timepoint [4] 461334 0
(i) At Baseline (T1) - Week 0 (ii) Within two weeks post-intervention - i.e. approximately Week 6-7 after completing Step 1 (T2a) or Step 2 (T2b) only, OR Week 14 after completing Step 1 AND Step 2 (iii) 2mo post-intervention follow-up (T3) - ie., approximately Week 14 after completing Step 1 (T2a) OR Step 2 (T2b) only, or Week 21 after completing Step 1 AND Step 2

Eligibility
Key inclusion criteria
• Aged 18 years or older at time of recruitment
• Confirmed diagnosis of ovarian cancer and being supported by Ovarian Cancer Australia
• Is English speaking and able to read English (the screening measures and the intervention are only available in English for this study).
• Reports mild to severe fatigue based on a series of screening questions administered via phone prior to recruitment
• Phase 1 recruitment only: Residing in rural and remote areas of Australia based on residential postcodes with Modified Monash Model (MMM) 2 or above
Minimum age
18 Years
Maximum age
No limit
Sex
Females
Healthy volunteers
No
Key exclusion criteria
At clinical screening interview is identified as:
• Likely experiencing a significant sleep disorder and would better benefit from usual care CBT sleep intervention (CAN-Sleep)
• Experiencing psychosis, significant psychological distress or risk of suicide or self-harm
• Not experiencing persistent fatigue (i.e., symptom duration too brief)

Study design
Purpose of the study
Treatment
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
ACT,NSW,NT,QLD,SA,TAS,WA,VIC

Funding & Sponsors
Funding source category [1] 321792 0
Government body
Name [1] 321792 0
Cancer Australia
Country [1] 321792 0
Australia
Primary sponsor type
Commercial sector/Industry
Name
Ovarian Cancer Australia
Address
Country
Australia
Secondary sponsor category [1] 324640 0
None
Name [1] 324640 0
Address [1] 324640 0
Country [1] 324640 0

Ethics approval
Ethics application status
Submitted, not yet approved
Ethics committee name [1] 320337 0
The University of Sydney Human Research Ethics Committee
Ethics committee address [1] 320337 0
Ethics committee country [1] 320337 0
Australia
Date submitted for ethics approval [1] 320337 0
06/03/2026
Approval date [1] 320337 0
Ethics approval number [1] 320337 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 150134 0
Dr Lauren Wlliams
Address 150134 0
Queen Victoria Women's Centre, Level 1, 210 Lonsdale St Melbourne VIC 3000. Australia
Country 150134 0
Australia
Phone 150134 0
+61412200245
Fax 150134 0
Email 150134 0
Contact person for public queries
Name 150135 0
Olivia Chung
Address 150135 0
Queen Victoria Women's Centre, Level 1, 210 Lonsdale St Melbourne VIC 3000. Australia
Country 150135 0
Australia
Phone 150135 0
+61392899774
Fax 150135 0
Email 150135 0
Contact person for scientific queries
Name 150136 0
Olivia Chung
Address 150136 0
Queen Victoria Women's Centre, Level 1, 210 Lonsdale St Melbourne VIC 3000. Australia
Country 150136 0
Australia
Phone 150136 0
+61392899774
Fax 150136 0
Email 150136 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.